Craving, Binge Eating and Obesity

Conditions

Binge Eating Disorder | Obesity

What is the purpose of this trial?

This research study is designed to look at the effectiveness of bupropion for reducing binge eating in overweight persons with binge eating problems. Participants in the study will receive either bupropion or placebo ("sugar" pill, inactive medication) as an outpatient for eight weeks. In addition, participants will be given the option to receive 8 weeks of free behavioral weight loss treatment. This treatment, known to be effective for reducing binge eating and helping people lose weight, will be administered following the medication phase and at no cost.

It is expected that compared to placebo, bupropion will produce greater reductions in binge eating.



Participation Guidelines

Age:
18 Years - 65 Years
Gender:
Female

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
December 2005
Last Updated:
February 12, 2014
Study HIC#:
0511000832

Clinicaltrials.gov ID: NCT00414167